ARCHIVES

Academic Oncologists Losing Control Over Phase I Trials As For-Profits Expand

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Columbia-Presbyterian Cancer center to Be Renamed After Donor Herbert Irving

December 6, 1996

In Brief: Eight Site Visits at Prospective Comprehensive Centers Scheduled For NCCAB Members In ’75, 76

July 4, 1975

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987

ONS Forms More Special Interest Groups For Members

May 11, 1990

In Brief: ASTRO Officers Named; AACR Fellowships Available; NRC Won’t Revoke NIH License

November 10, 1995

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014